Kailera Therapeutics believes it can stand out in a crowded and competitive market for obesity medicines. Global clinical trials underway could help build the case for differentiation, and the company
Behavioral Health Demand Has Increased by 62% Since 2018. What the Industry Needs to Know
Behavioral health utilization surged by 62.6% since 2018, according to a new report from Trilliant Health. To address this issue, the industry needs to expand the workforce and integrate behavioral
Your Doctors and Nurses Are Burned Out. Here’s What They Need
Doctors and nurses are under more pressure now more than ever to perform at their best, but many simply aren’t given the right support to meet those expectations. When they
CMS’ New ‘App Store’ Is Trying to Turn Interoperability Into a Digital Health Distribution System
This month, the Centers for Medicare & Medicaid Services announced the first wave of tools and partnerships under its Health Tech Ecosystem initiative — including the novel Medicare App Library
Wisp, Visby Partner to Expand Access to At-Home STI Test
Wisp, a women’s telehealth company, launched a partnership with Visby Medical on Thursday to increase access to Visby’s at-home polymerase chain reaction (PCR) test for sexually transmitted infections. New York
The Key Biomarkers Changing How and When We Diagnose Alzheimer’s Disease
Alzheimer’s disease continues to be one of the most daunting public health challenges of our time. In the United States alone, one in nine people over age 65 is living
Why Innovaccer Is Pouring $250M into Its Agentic AI Platform
Healthcare AI company Innovaccer announced on Wednesday that it is committing $250 million over the next three years to build out its platform of AI agents, which perform tasks across
New Bill Seeks to Lower Out-of-Pocket Drug Costs
Rep. Greg Murphy (R-North Carolina) introduced the Every Dollar Counts Act on Tuesday. It would ensure out-of-pocket costs for covered prescription drugs are applied toward patients’ deductibles and maximum out-of-pocket
Eli Lilly Buys Startup CrossBridge Bio to Bring a More Powerful Strike to Tumors
Antibody drug conjugates continue to be a robust area for research and dealmaking, and Eli Lilly’s latest move in this space is the acquisition of CrossBridge Bio, a preclinical startup
Heartflow Sues Cardiac AI Rival Cleerly Over Alleged IP Theft
AI-powered cardiac imaging company HeartFlow sued its competitor Cleerly this week, claiming the company infringed on its patents and misused proprietary technology to build a competing platform. The lawsuit, filed









